Table 1.
Tumor | Lymphoma type/stage | RUVBL1% staining/average intensity | BCL6% staining/average intensity | % staining×average intensity |
|
---|---|---|---|---|---|
RUVBL1 | BCL6 | ||||
T cell | Localized (stage 1) | ||||
1 | Anaplastic large cell | 80/3+ | 50/2+ | 240 | 100 |
2 | Anaplastic large cell | 85/3+ | 50/2+ | 255 | 100 |
Advanced (stages 3 and 4) | |||||
3 | Anaplastic large cell | 80/2+ | 0 | 160 | 0 |
4 | Peripheral | 80/2+ | 0 | 160 | 0 |
5 | Large cell (immunoblastic), peripheral | 85/3+ | 10/2.5+ | 255 | 25 |
6 | Large cell | 80/2+ | 25/2+ | 160 | 50 |
7 | Delta/gamma peripheral | 90/3+ | 25/2+ | 270 | 50 |
8 | Peripheral | 67/3+ | 30/2+ | 201 | 60 |
9 | Anaplastic large cell | 90/3+ | 40/2+ | 270 | 80 |
Avr 219 | 51.67 | ||||
B cell | Localized (stage 1) | ||||
10 | High grade, EBV-related | 70/2+/mostly big cells | 40/1.5+/mostly small cells | 140 | 60 |
11 | DLBL, follicular origin | 50/2+ | 50/1.5+ | 100 | 75 |
12 | Large cell, follicular origin | 85/2.5+ | 50/3+ | 212.5 | 150 |
13 | DLBL | 60/2+ | 70/2+ | 120 | 140 |
14 | DLBL, follicular center type | 80/1.5+ | 80/3+ | 120 | 240 |
15 | DLBL, non-germinal center-like | 90/3+ | 85/2.5+ | 270 | 212.5 |
Advanced (stages 3 and 4) | |||||
16 | Mantle cell | 95/3+ | 5/2.5+ | 285 | 12.5 |
17 | DLBL | 70/1.5+ | 25/1.5+ | 105 | 37.5 |
18 | Large cell, follicular origin | 60/2.5+ | 25/2.5+ | 150 | 62.5 |
19 | DLBL, CD5+ | 80/2.5+ | 40/2+ | 200 | 80 |
20 | DLBL with anaplastic features | 70/3+ | 50/2+ | 210 | 100 |
21 | Large cell, activated B cell type | 90/3+ | 50/2.5+ | 270 | 125 |
22 | DLBL, germinal center-like | 90/3+ | 60/2.5+ | 270 | 150 |
Avr 188.65 | 111.15 |
DLBL: Diffuse large B cell lymphoma; EBV: Epstein-Barr Virus.